Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
16.46 USD | +1.34% | -52.39% | -56.79% |
Jun. 04 | Inhibrx Biosciences Insider Bought Shares Worth $4,927,580, According to a Recent SEC Filing | MT |
May. 31 | Inhibrx, Inc.(NasdaqGM:INBX) dropped from S&P Biotechnology Select Industry Index | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-56.79% | 1.79B | |
+19.04% | 125B | |
+14.48% | 108B | |
-4.55% | 24.57B | |
+3.23% | 22.82B | |
-10.44% | 18.19B | |
-41.74% | 16.54B | |
-12.89% | 16.5B | |
+2.99% | 13.39B | |
+28.53% | 11.1B |
- Stock Market
- Equities
- INBX Stock
- News Inhibrx, Inc.
- Inhibrx Shares Fall After Q4 Net Loss Widens